PolyPid
PYPD
5 hedge funds and large institutions have $82.9K invested in PolyPid in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.09% more ownership
Funds ownership: 1.24% → 1.33% (+0.09%)
11% less capital invested
Capital invested by funds: $93.2K → $82.9K (-$10.2K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.57K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$504 |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$28 |
| 3 |
YLHM
Yelin Lapidot Holdings Management
Tel Aviv,
Israel
|
-$4 |
PYPD Hedge Fund Activity: Q4 2023 in Review
5 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q4 2023, worth a combined $82.9K — down 11% from $93.2K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PYPD positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.57K. The largest seller was Osaic Holdings, cutting an estimated $504.
- 5 institutional investors held PolyPid (PYPD) as of Q4 2023, up from 4 in Q3 2023.
- Funds reported $82.9K of PolyPid stock for Q4 2023, down 11% quarter-over-quarter.
- 1 fund opened new PolyPid positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest PolyPid buyer in Q4 2023 was Morgan Stanley, an estimated $3.57K added.
- The largest PolyPid seller in Q4 2023 was Osaic Holdings, an estimated $504 sold.
Based on aggregated 13F filings for Q4 2023.